ACG 2025 – What to Watch. AI Endoscopy, Metabolic IBD, and the Future of CRC Screening
Introduction As 2025 draws to a close, the ripple effects of the CMS pause on broad coverage of anti-obesity GLP-1 receptor agonists are still being felt across the American healthcare landscape. For many clinicians, that single administrative decision crystallized the tension between scientific progress and system inertia. Drugs such as semaglutide and tirzepatide have reshaped […]
Capsule Endoscopy + AI – What’s Already Available in the U.S.
Introduction – Innovation Moving Faster Than Policy As clinicians, we often find ourselves practicing at the intersection of discovery and delay. On one side, science is advancing at unprecedented speed; on the other, policy and reimbursement systems struggle to keep pace. The ongoing CMS pause on broad coverage of anti-obesity GLP-1 receptor agonists is a […]
AI-Assisted Colonoscopy in the Real World – Lessons from the Latest U.S. Multicenter Trial
Introduction – Policy Stagnation, Technologic Acceleration As we enter the last quarter of 2025, the effects of the CMS pause on broad coverage for anti-obesity GLP-1 receptor agonists continue to ripple across American medicine. For many clinicians, the decision has become a symbol of how regulation and reimbursement can lag far behind scientific progress. Gastroenterologists, […]
The First Cloud-Based AI System for Colonoscopy – What FDA Clearance Means for U.S. Clinics
Introduction: When Policy Slows Down, Technology Speeds Up This year has reminded us how uneven the pace of medical progress can be. In one corner of healthcare, the CMS pause on broad coverage of anti-obesity GLP-1 drugs continues to limit access for millions of patients. That policy decision has left clinicians watching powerful metabolic therapies […]
State Pilots and What This Means for MASH and IBD Patients with Obesity
How the CMS Pause on GLP-1 Coverage Shapes Patient Access in the U.S. In 2025, the debate over coverage of anti-obesity GLP-1 drugs reached a critical point. The U.S. Centers for Medicare and Medicaid Services (CMS) effectively paused efforts to expand reimbursement for medications such as Wegovy® (semaglutide) and Zepbound™ (tirzepatide), citing the need for […]
Obefasimod (ABX464) in Ulcerative Colitis – What the Phase 3 Results Mean for U.S. Approval
Introduction – When Innovation Meets Momentum By Dr. Bruce E. Sands, MD, MS – Chief of Gastroenterology, Mount Sinai Hospital, New York If 2024 has shown us anything, it’s that the pace of medical innovation continues to far outstrip the speed of coverage reform. The ongoing CMS pause on broad coverage of GLP-1 anti-obesity drugs […]
How to Take Dicyclomine (Bentyl) – Onset, Duration, Dosing Basics, and Interactions
How and when the drug starts working Many people taking Dicyclomine for the first time want to know how quickly they should expect relief. The answer is that the medication generally begins to work within 30 to 60 minutes, but the range is wide because several factors influence how rapidly it is absorbed. Some individuals […]
Dicyclomine (Bentyl) – What It Is, How It Works, and What It Treats
What Is Dicyclomine / Bentyl Dicyclomine is a prescription antispasmodic medicine used primarily in gastroenterology, and it has been on the market for several decades under various brand names, most famously, Bentyl. In clinical practice it is known as a targeted agent for relieving intestinal muscle spasms, and it belongs to the pharmacological group of […]
Dicyclomine for IBS, Gastritis, Diarrhea, Gas, and Bloating – What It Really Helps With
Dicyclomine for IBS Dicyclomine (Bentyl) has a long-standing role in the management of Irritable Bowel Syndrome (IBS), but its usefulness depends heavily on the nature of a patient’s symptoms and the accuracy of the diagnosis. IBS is classified as a functional gastrointestinal disorder, meaning that the bowels appear structurally normal yet behave in an overly […]
Diet and Lifestyle on Allopurinol: What Foods to Avoid and General ‘Don’ts’
Who Is Usually Prescribed Allopurinol Allopurinol is most commonly prescribed to people who have chronically elevated uric acid levels, especially those who experience gout attacks or have a history of uric acid kidney stones (Allopurinol: What It Is, How It Works, and What It Treats). It is also used in individuals whose uric acid is […]